Hence, we took advantage of our previously described capillary isoelectric focusing (CIEF) immunoassay [9] to investigate qualitative modifications of CSF serpinA1 in AD, Lewy body disorders (LBDs, including PD and DLB) and control subjects. This evidence concerns the gene SERPINA1 and Alzheimer disease.